Robbins Farley LLC Viatris Inc Transaction History

Robbins Farley LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$9.02 - $10.29 $559 - $637	62 New	62 $0
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $39 - $61	-4 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$12.09 - $14.68 $169 - $205	-14 Reduced 77.78%	4 $0
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $238 - $272	18 New	18 $0
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $233 - $290	-18 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $190 - $259	-14 Reduced 43.75%	18 $0
Q4 2020 Mar 11, 2021	BUY	$14.3 - $18.74 $443 - $580	31 Added 3100.0%	32 $1,000
Q4 2020 Mar 04, 2021	BUY	$14.3 - $18.74 $14 - $18	1 New	1 $32,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

Stay updated on Robbins Farley LLC with notifications on news.